SILO PHARMA, INC. Transfer to Investments
SILO PHARMA, INC. (SILO) reported Transfer to Investments of $16.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:TransferToInvestments · last filed 2019-11-13
- 2018-09-30: Transfer to Investments 9 month $16.00K.
| Period end | Transfer to Investments 9 month |
|---|---|
| 2018-09-30 | $16.00K 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |